These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 6882004

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Estimation of treatment results and side-effects in patients with invasive uterine cervix cancer stage IIB-IVA treated with concurrent radiochemotherapy].
    Torbé B.
    Ann Acad Med Stetin; 2008; 54(1):28-40. PubMed ID: 19127807
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients.
    Ryu HS, Chun M, Chang KH, Chang HJ, Lee JP.
    Gynecol Oncol; 2005 Feb; 96(2):490-5. PubMed ID: 15661240
    [Abstract] [Full Text] [Related]

  • 28. NK cell activity in the presence of IL-12 is a prognostic assay to neoadjuvant chemotherapy in cervical cancer.
    Cosiski Marana HR, Santana da Silva J, Moreira de Andrade J.
    Gynecol Oncol; 2000 Sep; 78(3 Pt 1):318-23. PubMed ID: 10985887
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
    Bierman PJ, Abe F, Buyukberber S, Ino K, Talmadge JE.
    In Vivo; 2000 Sep; 14(1):221-36. PubMed ID: 10757081
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Optimal management of locally advanced cervical carcinoma.
    Keys H, Gibbons SK.
    J Natl Cancer Inst Monogr; 1996 Sep; (21):89-92. PubMed ID: 9023835
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Phase-II randomized study of preoperative IL-2 administration in radically operable gastric cancer patients.
    Romano F, Piacentini MG, Franciosi C, Caprotti R, De Fina S, Cesana G, Uggeri F, Conti M, Uggeri F.
    Hepatogastroenterology; 2004 Sep; 51(60):1872-6. PubMed ID: 15532847
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
    Pötter R, Dimopoulos J, Georg P, Lang S, Waldhäusl C, Wachter-Gerstner N, Weitmann H, Reinthaller A, Knocke TH, Wachter S, Kirisits C.
    Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer).
    Classe JM, Rauch P, Rodier JF, Morice P, Stoeckle E, Lasry S, Houvenaeghel G, Groupe des Chirurgiens de Centre de Lutte Contre le Cancer.
    Gynecol Oncol; 2006 Sep; 102(3):523-9. PubMed ID: 16504274
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.